CEBPA Methylation as a Prognostic Biomarker in Adult Patients with De Novo AML.

被引：0
|
作者：
Chen, Hsin-Yu [1 ]
Lin, Tsung-Chin [1 ]
Chou, Wen-Chien [1 ]
Hou, Hsin-An [1 ]
Tien, Hwei-Fang [1 ]
Lin, Liang-In [1 ]
机构：
[1] Natl Taiwan Univ, Taipei 10764, Taiwan
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：628 / 628
页数：1
相关论文
共 50 条
  • [41] CLINICAL, MORPHOLOGIC, CYTOGENETIC AND PROGNOSTIC IMPLICATIONS OF CD34 EXPRESSION IN CHILDHOOD AND ADULT DE-NOVO AML
    SPERLING, C
    BUCHNER, T
    CREUTZIG, U
    RITTER, J
    HARBOTT, J
    FONATSCH, C
    SAUERLAND, C
    MIELCAREK, M
    MASCHMEYER, G
    LOFFLER, H
    LUDWIG, WD
    LEUKEMIA & LYMPHOMA, 1995, 17 (5-6) : 417 - 426
  • [42] Prognostic value of serum progranulin in de novo adult acute myeloid leukemia patients
    Azazzi, Mohamed O.
    El-Ghammaz, Amro M. S.
    Mohamed, Haydi S.
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (01) : 25 - 31
  • [43] Prognostic Value of Serum Progranulin in De Novo Adult Acute Myeloid Leukemia Patients
    Azzazi, Mohamed
    El Ghammaz, Amro
    Mohamed, Haydi Sayed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S225 - S225
  • [44] Expression and prognostic significance of survivin in de novo acute myeloid leukemia (AML).
    Adida, C
    Recher, C
    Raffoux, E
    Daniel, MT
    Taksin, AL
    Rousselot, P
    Sigaux, F
    Degos, L
    Altieri, DC
    Dombret, H
    BLOOD, 2000, 96 (11) : 698A - 698A
  • [45] Rearrangements of the NUP98 gene in adult patients with de novo acute myeloid leukemia (AML)
    Ransdorfova, Sarka
    Markova, Jana
    Valerianova, Marie
    Mendlikova, Iveta
    Rochlova, Kristina
    Zemanova, Zuzana
    Lizcova, Libuse
    Pavlistova, Lenka
    Jonasova, Anna
    Valka, Jan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1580 - 1580
  • [46] Methylation of DNA Repair Genes as a Prognostic Biomarker in AML of a TCGA-LAML Cohort
    Park, Sholhui
    So, Min-Kyung
    Huh, Jungwon
    CLINICAL LABORATORY, 2022, 68 (07) : 1508 - 1513
  • [47] Frequency and Prognostic Impact of CEBPA Proximal, Distal and Core Promoter Methylation in Normal Karyotype AML: A Study on 623 Cases
    Fasan, Annette
    Alpermann, Tamara
    Haferlach, Claudia
    Grossmann, Vera
    Roller, Andreas
    Kohlmann, Alexander
    Eder, Christiane
    Kern, Wolfgang
    Haferlach, Torsten
    Schnittger, Susanne
    PLOS ONE, 2013, 8 (02):
  • [48] Activation of the p21-RAS pathway is associated with sensitivity against high dose Ara-C in patients with de novo AML.
    Illmer, T
    Thiede, C
    Stadler, S
    Neubauer, A
    Ehninger, G
    Schaich, M
    BLOOD, 2003, 102 (11) : 217B - 217B
  • [49] Validation of the ELN-2017 risk classification in younger adult patients (pts) with AML.
    Boddu, Prajwal
    Kadia, Tapan M.
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Borthakur, Gautam
    Konopleva, Marina
    Jabbour, Elias
    Daver, Naval Guastad
    Dinardo, Courtney Denton
    Naqvi, Kiran
    Yilmaz, Musa
    Short, Nicholas James
    Nogueras-Gonzalez, Graciela M.
    Pierce, Sherry
    Kantarjian, Hagop M.
    Ravandi, Farhad
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Treatment outcomes in older adolescent and young adult (AYA) patients with newly diagnosed AML.
    Canner, J. A.
    Alonzo, T. A.
    Franklin, J.
    Freyer, D. R.
    Gamis, A. S.
    Gerbing, R. B.
    Lange, B.
    Meshinchi, S.
    Woods, W. G.
    Perentesis, J. P.
    Horan, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345